Der Report
Tiefgehende Einblicke in Unternehmensfinanzierung, Wachstumsstrategien und Markterkenntnisse der innovativsten Unternehmen der Welt
7 Berichte und es werden mehr
Ginkgo Bioworks Raises $350M in Series E
Ginkgo Bioworks, a Biotech company based in 27 Drydock Avenue, Boston, MA 02210, has raised $350M in Series E at a $4.9B valuation led by Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors.
Ginkgo Bioworks raises $1.5B PIPE at $15B valuation
Ginkgo Bioworks raises $1.5B in PIPE at $15B valuation. Synthetic biology and organism engineering platform...
Ginkgo Bioworks raises $350M Series E at $4.9B valuation
Ginkgo Bioworks raises $350M in Series E at $4.9B valuation. Synthetic biology and organism engineering...
Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation
Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.
Ginkgo Bioworks Headquarters - Office Location & Address
Discover Ginkgo Bioworks's headquarters at 27 Drydock Ave, Boston, MA 02210. Synthetic biology company. Learn about the office facilities and work environment.
Umami Bioworks Headquarters - Office Location & Address
Discover Umami Bioworks's headquarters at 61 Science Park Rd, Singapore, 117525. Cell-cultured seafood production. Learn about the office facilities and work environment.
BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology
BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.
7 Berichte angezeigt • Seite 1 • Kategorie: all
Bleiben Sie dem Markt voraus
Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.